Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

CANBRIDGE-B

0.800
-0.030-3.61%
Volume:4.86M
Turnover:3.96M
Market Cap:339.87M
PE:-0.70
High:0.890
Open:0.860
Low:0.780
Close:0.830
Loading ...
OverviewCompanyNewsFilings

Company Profile

Company Name:
CANBRIDGE-B
Exchange:
SEHK
Establishment Date:
2012
Employees:
67
Office Location:
Suzhou Industrial Park, Building 21,Unit 18, 6th Floor,No. 388 Xinping Street,Suzhou,China
Website:
http://www.ssitimber.com.hk
Zip Code:
- -
Phone:
86 10 6478 0016
Fax:
- -
Introduction:
Cambridge Pharmaceuticals Inc is a China-based company mainly engaged in the research, development and commercialization of rare disease treatments. The Company's main businesses are the development, production, promotion and sales of medical products. The Company's main product is the glycosylated fusion protein CAN008 for the treatment of glioblastoma (GBM). The Company's products are mainly used in rare diseases such as Hunter's syndrome (MPS II), rare tumors and other fields. The Company is also engaged in the development of gene therapy.

Directors

Name
Position
XUE Qun
Chairman of the Board,Executive Director,Chairman of the Nomination Committee
James Arthur Geraghty
Independent Director,Member of the Nomination Committee,Audit Committee Member
Richard James Gregory
Independent Director,Chairman of the Remuneration and Assessment Committee,Audit Committee Member
CHEN Bing Jun
Independent Director,Member of the Nomination Committee,Audit Committee Chairman
HU Lan
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee
ZHAO Wei
Director,Member of the Remuneration and Assessment Committee

Shareholders

Name
Position
XUE Qun
CEO
MA Qian
Corporate Secretary
HUANG Wei Chao
Corporate Secretary
Gerald Cox
Other Senior Executives,Other Senior Executives